Allogene Therapeutics, Inc.
ALLO
$1.45
$0.053.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.94M | -66.29M | -66.36M | -65.00M | -85.78M |
| Total Depreciation and Amortization | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.74M | 27.85M | 15.88M | 9.99M | 33.67M |
| Change in Net Operating Assets | 5.27M | -8.88M | -16.75M | -4.44M | -5.07M |
| Cash from Operations | -36.70M | -44.12M | -63.59M | -55.90M | -53.71M |
| Capital Expenditure | -257.00K | -429.00K | 0.00 | -8.00K | -181.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.19M | -75.56M | 74.61M | 22.14M | 67.64M |
| Cash from Investing | 54.93M | -75.99M | 74.61M | 22.13M | 67.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.74M | 679.00K | 106.32M | 1.65M | 155.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 2.28M | -- | -- |
| Cash from Financing | 5.74M | 679.00K | 108.60M | 1.65M | 155.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.98M | -119.43M | 119.63M | -32.12M | 13.91M |